Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer
- 21 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Langenbecks Archiv für Chirurgie
- Vol. 406 (5), 1443-1452
- https://doi.org/10.1007/s00423-020-02065-w
Abstract
Introduction The NCCN classification of resectability in pancreatic head cancer does not consider preoperative radiological tumour ≤ 180° contact with portal vein/superior mesenteric vein (PV/SMV) as a negative prognostic feature. The aim of this study is to evaluate whether this factor is associated with higher rate of incomplete resection and poorer survival. Methods All patients considered for pancreatic resection between 2012 and 2017 at two Spanish referral centres were included. Patients with borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC) according to NCCN classification were excluded. Preoperative CT scans were reviewed by dedicated radiologists to identify radiologic tumour contact with PV/SMV. Results Out of 302, 71 patients were finally included in this study. Twenty-two (31%) patients showed tumour-PV/SMV contact (group 1) and 49 (69%) did not show any contact (group 2). Patients in group 1 showed a statistically significantly higher rate of R1 and R1-direct margins compared with group 2 (95 vs 28% and 77 vs 10%) and lower median survival (24 vs 41 months, p = 0.02). Preoperative contact with PV/SMV, lymph node metastases, R1-direct margin and NO adjuvant chemotherapy were significantly associated with disease-specific survival at multivariate analysis. Conclusion Preoperative radiological tumour contact with PV/SMV in patients with NCCN resectable PDAC is associated with high rate of pathologic positive margins following surgery and poorer survival.This publication has 30 references indexed in Scilit:
- Should the Portal Vein Be Routinely Resected During Pancreaticoduodenectomy For Adenocarcinoma?Annals of Surgery, 2013
- Imaging of Pancreatic Adenocarcinoma: Update on Staging/ResectabilityRadiologic Clinics of North America, 2012
- Survival After Pancreaticoduodenectomy is not Improved by Extending Resections to Achieve Negative MarginsAnnals of Surgery, 2009
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP)HPB, 2009
- Influence of Resection Margins and Treatment on Survival in Patients With Pancreatic CancerArchives of Surgery, 2008
- Resection margins and R1 rates in pancreatic cancer – are we there yet?Histopathology, 2007
- Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic AdenocarcinomaAnnals of Surgery, 2007
- Redefining the R1 resection in pancreatic cancerBritish Journal of Surgery, 2006
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004